Company Email Format Management

Imugene Limited

Biotechnology Research Au 36 employees

Employees: 36
Contacts: 4
Emails: 4
Phones: 1

imugene.com LinkedIn Crunchbase

Imugene Limited Overview

Headquarters: Au
Website: imugene.com
Industry: Biotechnology Research
Employees: 36
Founded: 2013
Funding: 3.3M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immuno-oncology Cancer Vaccines Her-2+ cancers Mimotopes PD-1 biotechnology immunotherapy biotech immune system cancer experts B-cell peptide vaccines b-cell

About Imugene Limited

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts with extensive experience in developing new cancer therapies with many approved for sale and marketing for global markets. ASX: IMU

Imugene Limited Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Imugene Limited Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jakob Dupont, Md Ma		San Francisco Bay Area, United States	Email
Paul Hopper		Sydney, New South Wales, Australia	Email
Ursula Mccurry		San Francisco, California, United States	Email
Brad Glover	Biotech Executive - Board Member - Deal	San Francisco Bay Area, United States	Email Phone